←Back to Expert Scholars
Translational Medicine / 转化医学Neoadjuvant Immunotherapy, Lung Cancer
Mark Jain
MD
🏢Mount Sinai Health System🌐USA
Thoracic Medical Oncologist
25
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Mark Jain participates in thoracic oncology trials in early stage NSCLC, with interests in perioperative immunotherapy and ctDNA based monitoring. His work contributes to biomarker informed patient selection. He practices at Mount Sinai in New York.
Share:
🧪Research Fields 研究领域
lung cancer clinical trials
perioperative IO
biomarker development
ctDNA monitoring
resectable NSCLC
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Mark Jain 的研究动态
Follow Mark Jain's research updates
留下邮箱，当我们发布与 Mark Jain（Mount Sinai Health System）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment